-The Telegraph New Delhi: Many doctors across India have been offered prepaid cash cards as gifts by drug industry representatives over the past three years to try and influence prescriptions for patients, pharmaceuticals sales executives have said. While drug companies have long used largesse as "brand reminders" for doctors, a prepaid cash card leaked by an industry whistleblower appears to be the first evidence to suggest doctors are also being offered cash...

-The Hindu That the Union Health Ministry takes critical decisions affecting a large number of people without any scientific basis does not portend well for public health in India. Neither the ban imposed on the oral anti-diabetes drug pioglitazone on June 18 nor its revocation a month later with a requirement that the medicine be sold with a boxed warning highlighting the adverse side-effect of bladder cancer was based on any...

-The Telegraph New Delhi: Patients infected with the human immuno-deficiency virus (HIV) in the northeastern states have been unable to undergo a key test required to start anti-HIV drugs for several weeks because of delays in procurement by government agencies, patient interest groups said today. The Indian Drug Users Forum said several government HIV-treatment centres across Manipur, Meghalaya, Nagaland and Tripura are facing a "complete stock-out" of biochemical reagents that measure levels...

-The Telegraph The Union health ministry has banned the manufacture and sale of a pain-reliever called dextropropoxyphene (DPPP) amid steadily growing concerns worldwide that this opioid analgesic drug poses several serious health risks, including heart damage. The health ministry, in a drug withdrawal notification, has suspended the manufacture, distribution and sale of all medicines containing DPPP saying the central government has determined that this drug is likely to involve risk to humans...

-The Business Standard Govt should streamline its free medicines plan The Centre is reportedly going to shelve a plan to procure generic drugs for free supply to patients throughout the country. This is a serious error. Reportedly, states will instead be asked to do so; but, if a perceived inability to procure, stock and distribute these drugs is the reason for backtracking on the plan, how precisely will states be free of...